Real-world effectiveness of nirsevimab against respiratory syncytial virus disease in infants: a systematic review and meta-analysisReal-world effectiveness of nirsevimab against respiratory syncytial virus disease in infants: a systematic review and meta-analysis
The Lancet Child & Adolescent Health · 2025 · Review
The Lancet Child & Adolescent Health · 2025 · Review